Potential Savings in the Cost of Caring for Alzheimer’s DiseaseTreatment with Rivastigmine

被引:0
|
作者
A. Brett Hauber
Josephine A. Mauskopf
Edward H. Snyder
机构
[1] Parametric Research Corporation Warrington,
[2] RTI Health Solutions,undefined
[3] Research Triangle Institute,undefined
[4] Novartis Pharma A.G.,undefined
[5] East Hanover,undefined
关键词
Cost Saving; Rivastigmine; Pharmacoeconomic Analysis; Drug Treatment Cost; Average Total Duration;
D O I
10.2165/00019053-200018060-00008
中图分类号
学科分类号
摘要
引用
收藏
页码:609 / 612
页数:3
相关论文
共 50 条
  • [31] Potential for cost savings during the drying
    Schuster, A.
    Voigt, A.
    WOCHENBLATT FUR PAPIERFABRIKATION, 2010, 138 (10): : 826 - 827
  • [32] A Cost-Utility Analysis of Rivastigmine Transdermal System for the Treatment of Patients with Alzheimer's Disease in Mexico
    Cruz, Samaria
    Briones, Bernardo
    Garcia-Contreras, Fernando
    NEUROLOGY, 2011, 76 (09) : A231 - A231
  • [33] UAE's engine choice offers USAF potential cost savings
    Kandebo, SW
    AVIATION WEEK & SPACE TECHNOLOGY, 2000, 152 (16): : 39 - 40
  • [34] Cost-Utility of the Rivastigmine Transdermal Patch in the Management of Patients with Moderate Alzheimer's Disease in the US
    Nagy, Balazs
    Brennan, Alan
    Brandtmueller, Agnes
    Thomas, Simu K.
    Sullivan, Sean D.
    Akehurst, Ron
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2008, 16 (03): : A106 - A107
  • [35] Cholinesterase inhibitors in Alzheimer's disease: donepezil or rivastigmine?
    Sharma, JC
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2002, 56 (06) : 414 - 415
  • [36] Rivastigmine patch and massage for Alzheimer's disease patients
    Satoh, Sachiko
    Kajiwara, Mutsuko
    Kiyokawa, Emi
    Toukairin, Yoshiko
    Fujii, Masahiko
    Sasaki, Hidetada
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2013, 13 (02) : 515 - 516
  • [37] Rivastigmine in patients with Alzheimer's disease and concurrent hypertension
    Erkinjuntti, T
    Skoog, I
    Lane, R
    Andrews, C
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2002, 56 (10) : 791 - 796
  • [38] Prediction of treatment response to rivastigmine in Alzheimer's dementia
    Adler, G
    Brassen, S
    Chwalek, K
    Dieter, B
    Teufel, M
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2004, 75 (02): : 292 - 294
  • [39] Rivastigmine - A review of its use in Alzheimer's disease
    Spencer, CM
    Noble, S
    DRUGS & AGING, 1998, 13 (05) : 391 - 411
  • [40] Rivastigmine reduces caregiver burden in Alzheimer's disease
    Hill, J
    Fillit, H
    Chang, S
    GERONTOLOGIST, 2002, 42 : 209 - 209